|
Kaposi's Sarcoma Health Article
|
|
Table of Contents
Definition
Description
Demographics
Causes and symptoms
Diagnosis
Treatment team
Clinical staging, treatments, and prognosis
Coping with cancer treatment
Clinical trials
Prevention
Special concerns
Angiogenesis
Cryotherapy
Disseminated
Highly active antiretroviral therapy (HAART)
Iatrogenic
Immunosuppressive
Indolent
Liposomes
Opportunistic infections (OI)
|
DefinitionKaposi's sarcoma (KS) is a cancer of the skin, mucous membranes, and blood vessels; it is the most common form of cancer in AIDS patients. It was named for Dr. Moritz Kaposi (1837-1902), a Hungarian dermatologist who first described it in 1872. As of 2001, researchers disagree as to whether KS is a true cancer or a disorder of the skin that develops as a reaction to infection by a herpesvirus. DescriptionThe formal medical term for Kaposi's sarcoma is multiple idiopathic hemorrhagic sarcoma. This term means that KS develops in many different sites on the patient's skin or internal organs; that its cause is unknown; and that it is characterized by bleeding. The lesions (areas of diseased or damaged skin), which are usually round or elliptical in shape and a quarter of an inch to an inch in size, derive their characteristic purple or brownish color from blood leaking out of capillaries (small blood vessels) in the skin. In KS, the capillaries begin to grow too rapidly and irregularly, which causes them to become leaky and eventually break. The lesions themselves may become enlarged and bleed, or cause the mucous membranes of the patient's internal organs to bleed. There are three types of KS lesions, defined by their appearance:
As of 2001, KS is classified into five types:
|
advertisement |
|
Use of this Web site constitutes acceptance of our Terms and Conditions of Use and Privacy Policy.